Androgens and growth factors in prostate cancer: A transgenic perspective

Prostate Cancer and Prostatic Diseases

Volumn 3, Issue 4, 2000, Pages 224-228

  Greenberg, N M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Androgen receptor; Growth factor; Probasin; Transgenic

Indexed keywords

ANDROGEN; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; POLYPEPTIDE;

ANIMAL MODEL; ARTICLE; CANCER MODEL; CANCER RESEARCH; GENE MUTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; TRANSGENIC MOUSE;

EID: 0034505267     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500422     Document Type: Article

References (45)

1. The rat probasin gene promoter directs hormonally- and developmentally-regulated expression of a heterologous gene specifically to the prostate in transgenic mice
2. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma
3. Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes
4. SV40 large timor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
5. Characterization of a 54kDalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
6. T-antigen is bound to host proteins in SV-40 transformed cells
7. Prostate cancer in a transgenic mouse
8. Pathologic progression of autochthonous prostate cancer in the TRAMP model
9. Metastatic prostate cancer in a transgenic mouse
10. A transgenic mouse prostate cancer model
11. Androgen-independent prostate cancer progression in the TRAMP model
12. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence
13. Mutated human androgen receptor gene detected in a prostate cancer patient is also activated by estradiol
14. Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer
15. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
16. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor
17. Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a
18. Low incidence of androgen receptor gene mutations in human prostatic tumors using single stranded conformation polymorphism analysis
19. Distant metastatses from prostatic carcinoma express androgen receptor protein
20. The androgen receptor gene mutations database
21. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy
22. Androgen receptor gene expression in human prostate carcinoma cell lines
23. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: Measurement by color video image analysis
24. Human prostate cancer model: Roles of growth factors and extracellular matrices
25. The endocrinology and developmental biology of the prostate
26. Role of mesenchymal-epithelial interactions in normal and abnormal development of male urogenital glands
27. Growth factors as mediators of androgen action during the development of the male urogenital tract
28. Regulation of gene expression in the prostate
29. Growth factors and oncogenes in prostate cancer
30. Keratinocyte growth factor: A mediator of mesenchymal-epithelial interactions in the development of androgen target organs
31. Keratinocyte growth factor as mediator of mesenchymal-epithelial interactions in the development of androgen target organs
32. Changes in gene expression of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostates
33. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate
34. Overexpression of fibroblast growth factor-8 in human prostate cancer
35. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice
36. Stimulation of estrogen recepto-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
37. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element
38. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators
39. Dopaminergic and ligand-independent activation of steroid hormone receptors
40. HER-3 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells
41. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
42. The IGF-I axis in the prostate
43. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse
44. Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
45. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer